At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Active rTMS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation of Right Angular Gyrus.
In Brief
A clinical study evaluating Active rTMS and Placebo rTMS for Depersonalization Disorder. Completed, enrolled 81 participants across 2 sites.
Detailed Summary
The purpose of this study is to assess the therapeutic efficacy of transcranial magnetic stimulation in patients with depersonalization disorder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepersonalization Disorder
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartJun 2015
Primary CompletionOct 2022
TodayJul 2026
First PostedJun 19, 2015
Enrollment StartJun 19, 2015
Primary CompletionOct 10, 2022
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 11.0 years ago
Interventions
Active rTMSdevice
Strong electromagnetic fields (\~2Tesla) generated briefly but repetitively (1Hz) applied for 30mins, in five sessions per week for 3 weeks
Placebo rTMSdevice
Placebo electromagnetic fields generated briefly but repetitively applied for 30mins, in five sessions per week for 3 weeks